Scott Newsome

ASSOCIATE PROFESSOR

20072018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Multiple Sclerosis Medicine & Life Sciences
Optical Coherence Tomography Medicine & Life Sciences
Relapsing-Remitting Multiple Sclerosis Medicine & Life Sciences
Neuromyelitis Optica Medicine & Life Sciences
Ganglia Medicine & Life Sciences
Progressive Multifocal Leukoencephalopathy Medicine & Life Sciences
Optic Neuritis Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2018

Distinguishing among multiple sclerosis fallers, near-fallers and non-fallers

Fritz, N. E., Eloyan, A., Baynes, M., Newsome, S., Calabresi, P. & Zackowski, K. M., Jan 1 2018, In : Multiple Sclerosis and Related Disorders. 19, p. 99-104 6 p.

Research output: Contribution to journalArticle

Multiple Sclerosis
Walking
Logistic Models
Rehabilitation

Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN

Newsome, S., Scott, T. F., Arnold, D. L., Nelles, G., Hung, S., Cui, Y., Shang, S., Naylor, M. L. & Kremenchutzky, M., Jan 1 2018, In : Therapeutic Advances in Neurological Disorders. 11

Research output: Contribution to journalArticle

Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Safety
Recurrence
Magnetic Resonance Imaging

Radiation-induced myelitis: Initial and follow-up MRI and clinical features in patients at a single tertiary care institution during 20 years

Khan, M., Ambady, P., Kimbrough, D., Shoemaker, T., Terezakis, S., Blakeley, J., Newsome, S. & Izbudak, I., Aug 1 2018, In : American Journal of Neuroradiology. 39, 8, p. E90-E91

Research output: Contribution to journalArticle

Myelitis
Tertiary Healthcare
Radiation
Atrophy
Spinal Cord

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

EXPAND Clinical Investigators, Mar 31 2018, In : The Lancet. 391, 10127, p. 1263-1273 11 p.

Research output: Contribution to journalArticle

Chronic Progressive Multiple Sclerosis
Placebos
1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid
Bradycardia
Safety

Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis

Nguyen, J., Rothman, A., Fitzgerald, K., Whetstone, A., Syc-Mazurek, S., Aquino, J., Balcer, L. J., Frohman, E. M., Frohman, T. C., Crainiceanu, C. M., Beier, M., Newsome, S., Calabresi, P. & Saidha, S., May 2 2018, (Accepted/In press) In : Current Eye Research. p. 1-8 8 p.

Research output: Contribution to journalArticle

Visual Pathways
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Optical Coherence Tomography
Ganglia